(Q54594233)

1 June 2018

title

Performance of the fractional maximal effect method: comparative interaction studies of ciprofloxacin and protein synthesis inhibitors. (English)

1 reference

1 June 2018

3

Schentag JJ

1 reference

1 June 2018

author name string

Li RC

series ordinal

1

1 reference

1 June 2018

Nix DE

series ordinal

2

1 reference

1 June 2018

publication date

1 February 1996

1 reference

1 June 2018

published in

Journal of Chemotherapy

1 reference

1 June 2018

volume

8

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

25-32

1 reference

1 June 2018

A Method for Testing for Synergy with Any Number of Agents

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.1.25

Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.1.25

Comparison of Techniques for Measurement of in Vitro Antibiotic Synergism

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.1.25

Microbial kinetics of beta-lactam antibiotics against Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.1.25

Sulfamethoxazole-Trimethoprim-Polymyxin Therapy of Serious Multiply Drug-Resistant Serratia Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.1.25

Microbial Kinetics and Dependencies of Individual and Combined Antibiotic Inhibitors of Protein Biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.1.25

Pharmacodynamic modeling of bacterial kinetics: beta-lactam antibiotics against Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.1.25

The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.1.25

Nalidixic Acid: an Antibacterial Paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1996.8.1.25

21 January 2018

Identifiers

DOI

10.1179/JOC.1996.8.1.25

1 reference

1 June 2018

1 reference

1 June 2018